Orsolya Giricz, Ph.D.
Affiliations: | 2008 | Florida Atlantic University, Boca Raton, FL, United States |
Area:
Molecular BiologyGoogle:
"Orsolya Giricz"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Gregg B. Fields | grad student | 2008 | Florida Atlantic University | |
| (Metalloprotease profiling in melanoma.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Cotto-Rios XM, Agianian B, Gitego N, et al. (2020) Inhibitors of BRAF dimers using an allosteric site. Nature Communications. 11: 4370 |
| Bhagat TD, Von Ahrens D, Dawlaty M, et al. (2019) Lactate-mediated epigenetic reprogramming regulates formation of human pancreatic cancer-associated fibroblasts. Elife. 8 |
| Jasra S, Giricz O, Zeig-Owens R, et al. (2019) High Burden of Clonal Hematopoiesis in First Responders Exposed to the World Trade Center Disaster Blood. 134: 3720-3720 |
| Rahmani NE, Ramachandra N, Bhagat TD, et al. (2019) ASXL1 Mutations Are Associated with Widespread and Distinct DNA Methylation Alterations Blood. 134: 2989-2989 |
| Shastri A, Choudhary G, Teixeira M, et al. (2018) Antisense STAT3 inhibitor decreases viability of myelodysplastic and leukemic stem cells. The Journal of Clinical Investigation |
| Shah UA, Chung EY, Giricz O, et al. (2018) North American ATLL has a distinct mutational and transcriptional profile and responds to epigenetic therapies. Blood |
| Giricz O, Mo Y, Dahlman KB, et al. (2018) The RUNX1/IL-34/CSF-1R axis is an autocrinally regulated modulator of resistance to BRAF-V600E inhibition in melanoma. Jci Insight. 3 |
| Giricz O, Mo Y, Dahlman KB, et al. (2018) Abstract 2515: Aberrant expression of CSF1R in melanoma is driven through an endogenous viral promoter and it contributes to malignant growth and BRAF-inhibitor resistance Cancer Research. 78: 2515-2515 |
| Bhagat T, Chen S, Bartenstein M, et al. (2017) Wnt/ß-catenin activation by epigenetically aberrant stroma drives myelodysplastic syndrome. Cancer Research |
| Giricz O, Mo Y, Hu CY, et al. (2017) Abstract 3332: Aberrant expression of CSF1R in melanoma is driven through an endogenous viral promoter and it contributes to malignant growth and the acquisition of resistance against BRAF inhibition Cancer Research. 77: 3332-3332 |